임신 중 Methimazole을 복용한 산모의 자녀에서 발생한 선천성 피부 무형성증 1례
Aplasia Cutis Congenita in a Baby born to Hyperthyroid Mother Treated with Methimazole During Pregnancy: A Case Report
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Aplasia cutis congenita is a rare congenital anomaly characterized by focal absence of skin at birth. It most commonly manifests as a solitary defect on the scalp, but sometimes it may occur as multiple lesions. Frieden classified aplasia cutis congenita into nine types according to the associated anomalies, but a unifying theory has not been identified to explain the etiology of this disease. We report a case of a newborn with isolated aplasia cutis congenita on the scalp at birth, whose mother was treated with methimazole up to the 22 weeks of gestation due to hyperthyroidism.
Abstract
Aplasia cutis congenita is a rare congenital anomaly characterized by focal absence of skin at birth. It most commonly manifests as a solitary defect on the scalp, but sometimes it may occur as multiple lesions. Frieden classified aplasia cutis congenita into nine types according to the associated anomalies, but a unifying theory has not been identified to explain the etiology of this disease. We report a case of a newborn with isolated aplasia cutis congenita on the scalp at birth, whose mother was treated with methimazole up to the 22 weeks of gestation due to hyperthyroidism.
참고문헌 (16)
- Iwayama H., "Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero", Birth Defects Res A Clin Mol Teratol, 79, pp.680~684 (2007)
- Tasin L., "Aplasia cutis congenita and methimazole. a case report and literature review", Eur J Pediat Dermatol, 15, pp.117~120 (2005)
- Eghbalian F., "Aplasia cutis congenita after methimazole exposure in utero; a case report and literature review", Iran J Ped, 17, pp.293~296 (2007)
- Karg E., "Aplasia cutis congenita after methimazole exposure in utero", Pediatr Dermatol, 21, pp.491~494 (2004)
- Milham S., "Maternal methimazole and congenital defects in children", Teratology, 5, pp.125~126 (1972)
- 박 근, 장효찬, 정 현, 김희정, "임신 초기에 Methimazole 노출 후 발생한 선천성 피부 형성 부전증 1예", 대한피부과학회지, 44(5), pp.642~644 (2006), 대한피부과학회
- Van Dijke C.P., "Methimazole, carbimazole, and congenital skin defects", Ann Intern Med, 106, pp.60~61 (1987)
- Frieden I.J., "Aplasia cutis congenita: a clinical review and proposal for classification", J Am Acad Dermatol, 14, pp.646~660 (1986)
- Park J.M., "A case of aplasia cutis congenita", Korean J Dermatol, 38, pp.295~297 (2000)
- Gorlin R.J., "Syndromes of the head and neck", pp.494~498 (2001), New York: Oxford University Press
- Diav-Citrin O., "Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil", Teratology, 65, pp.38~44 (2002)
- Clementi M., "Methimazole embryopathy: delineation of the phenotype", Am J Med Genet, 83, pp.43~46 (1999)
- Martinez-Frias M.L., "Methimazole in animal feed and congenital aplasia cutis", Lancet, 339, pp.742~743 (1992)
- Mortimer R.H., "Methimazole and propylthiouracil equally cross the perfused human term placental lobule", Clin Endocrinol Metab, 82, pp.3099~3102 (1997)
- Kodama F., "Chromosome aberrations induced by clinical medicines", J Toxicol Sci, 5, pp.141~150 (1980)
- Demmel U., "Clinical aspects of congenital skin defects. Congenital skin defects on the head of the newborn", Eur J Pediatr, 121, pp.21~50 (1975)